Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

Segment Disclosures

9 Months Ended

Sep. 30, 2019

The Company has two reportable segments: EksoHealth (also referred to as the medical devices segment) and EksoWorks (also referred to as the industrial devices segment). The EksoHealth segment designs, engineers, manufactures, and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and sells exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The reportable segments are each managed separately because they serve distinct markets.

The Company evaluates performance and allocates resources based on segment gross profit margin. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

Segment reporting information is as follows:



	EksoHealth		EksoWorks		Other			Total
Three months ended September 30, 2019
Revenue	$	2,981	$	320	$	18		$	3,319
Cost of revenue	1,279		272		18			1,569
Gross profit	$	1,702	$	48	$	—		$	1,750

Three months ended September 30, 2018
Revenue	$	1,744	$	789	$	17		$	2,550
Cost of revenue	827		618		22			1,467
Gross profit	$	917	$	171	$	(5	)	$	1,083



	EksoHealth		EksoWorks		Other			Total
Nine Months Ended September 30, 2019
Revenue	$	8,635	$	1,536	$	26		$	10,197
Cost of revenue	3,906		1,356		26			5,288
Gross profit	$	4,729	$	180	$	—		$	4,909

Nine Months Ended September 30, 2018
Revenue	$	6,266	$	1,742	$	28		$	8,036
Cost of revenue	3,699		1,483		35			5,217
Gross profit	$	2,567	$	259	$	(7	)	$	2,819

Geographic information for revenue based on location of customers is as follows:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
United States	$	1,941	$	1,845	$	6,669	$	4,976
All Other	1,378		705		3,528		3,060
	$	3,319	$	2,550	$	10,197	$	8,036